New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 29, 2016 – Teva announced the FDA approval of an AB-rated generic version of ViiV Healthcare’s Epzicom (abacavir/lamivudine) 600 mg/300 mg tablets.
Download PDF
Return to publications
